ArticleAfrican health sciences2025
Assessment of serum cobalamin (vitamin B12) status among Human Immunodeficiency Virus (HIV) infected Nigerians with anaemia using serum methylmalonic acid.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Infections, reproductive health and non-communicable diseases.African health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cobalamin deficiency has been implicated as a contributor to anaemia in HIV disease. This study aimed to determine cobalamin status among antiretroviral therapy (ART)-naive HIV-infected patients with anaemia. Methods: A cross-sectional study was conducted and two categories of participants were recruited: ART-naive HIV-positive patients with anaemia (Group A) and HIV-negative individuals with anaemia (Group B). Socio-demographic and medical history was obtained. Methylmalonic acid (MMA) levels (an indirect measure of cobalamin level) was carried out by ELISA method. Full blood count was determined using haematology autoanalyser. CD4 count were done only on HIV-infected subjects using cyflowmeter. Data was analysed with SPSS software, version 20. Results: A total of 180 participants comprising 126 group A and 54 group B, aged between 18 and 60 years were studied. Cobalamin deficiency (indicated by high MMA level) was found to be significantly higher among group A participants (p=0.001). There was negative correlation between haemoglobin level and MMA (r= -0.147) (p= 0.547), as well as between CD4 count and MMA (r= -0.327) (p= 0.171), though not statistically significant. The age group commonly infected by HIV was 31 to 40years (42.1%). More females were affected with HIV disease with male to female ratio of 1:3.5. Conclusion: HIV-infection is associated with cobalamin deficiency and so contribute to anaemia of HIV infection. Larger population studies are recommended to ascertain the veracity of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.